The Department for Business, Energy and Industrial Strategy (BEIS) has issued guidance to the life sciences sector in the event of a no-deal Brexit.

The guidance covers four main areas:

  • Regulation and standards

The guidance confirms that the Medicines and Healthcare products Regulatory Agency (MHRA) will take on the EU's regulatory functions for medicines and devices in the UK. 

It also deals with market access for medicines and devices, clinical trials and batch testing recognition. 

  • Importing and exporting

You need to prepare for disruption to trade at the UK-EU border. The advice includes taking the following steps:

  1. Get a UK Economic Operator Registration and Identification (EORI) number so you can continue to import or export goods and apply for authorisations that will make customs processes easier for you;
  2. Decide if you want to hire an import-export agent, or make the declarations yourself;
  3. Contact the organisation that moves your goods (for example, a haulage firm) to find out what information they need to make the declarations for your goods, or if you will need to make them yourself.
  • Your employees

The guidance explains the position if you employ EU workers, how to apply for skilled/unskilled work visas and general advice about travelling to the EU. 

  • Personal data 

If you operate across the EU or exchange personal data with organisations in the EEA, there may be changes that you need to make before the UK leaves the EU.

At Markel Law we regularly comment on SME related matters.

Follow this link to find out more about Markel Law and how we can assist your business.